Individual sympathetic varicosities possess different sensitivities to alpha 2 and P2 receptor agonists and antagonists in mouse vas deferens

British Journal of Pharmacology

Volumn 128, Issue 8, 1999, Pages 1739-1753

  O'Connor, S C ^a   Brain, K L ^a   Bennett, M R ^a  

^a NONE

Author keywords

Autoinhibition; Calcium; Sympathetic; Varicosities; Vas deferens

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ARL 67157; AUTORECEPTOR; CALCIUM; CIBACRON BLUE F3GA; CLONIDINE; ENZYME INHIBITOR; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; IDAZOXAN; NORADRENALIN; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DRUG SENSITIVITY; MALE; MOUSE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; VAS DEFERENS;

EID: 0033429244     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702984     Document Type: Article

References (44)

1. BAILEY, S.J. & HOURANI, S.M. (1994). Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br. J. Pharmacol., 112, 219-225.
2. BENNETT, M.R & HO, S. (1992). Adenosine modulation of potassium currents in preganglionic nerve terminals of avian ciliary ganglia. Neurosci. Lett., 137, 41-44.
3. BLAKELEY, A.G., CUNNANE, T.C., MASKELL, T., MATHIE, A. & PETERSEN, S.A. (1984). Alpha-adrenoceptors and facilitation at a sympathetic neuroeffector junction. J. Autonomic Pharmacol., 4, 53-58.
4. BLAKELEY, A.G., DUNN, PM. & PETERSEN, S.A. (1988). A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro. Br. J. Pharmacol., 94, 37-46.
5. BOEHM, S. & HUCK, S. (1996). Inhibition of N-type calcium channels: the only mechanism by which presynaptic alpha 2-autoreceptors control sympathetic transmitter release. Eur. J. Neurosci., 8, 1924-1931.
6. BRAIN, K.L. & BENNETT, M.R (1997). Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and autoinhibition. J. Physiol., 502, 521-536.
7. + channel blockers on nerve impulses recorded from guinea-pig postganglionic sympathetic nerve terminals. J. Physiol., 489, 389-402.
8. BROCK, J.A., CUNNANE, T.C., STARKE, K. & WARDELL, C.F. (1990). Alpha 2-adrenoceptor-mediated autoinhibition of sympathetic transmitter release in guinea-pig vas deferens studied by intracellular and focal extracellular recording of junction potentials and currents. Naunyn-Schmiedebergs' Arch. Pharmacol., 342, 45-52.
9. BURNSTOCK, G. & HOLMAN, M.E. (1962). The transmission of excitation from autonomic nerves to smooth muscle. J. Physiol., 155, 115-133.
10. 2x-purinoceptor. Br. J. Pharmacol., 90, 383-391.
11. CHEUNG, A., BRAIN, K.L. & BENNETT, M.R. (1998). Calcium modulation in single sympathetic varicosities of mouse vas deferens during trains of impulses by sequestration and autoinhibition. Proc. Aust. Neurosci. Soc., 9, 137.
12. CRACK, B.E., POLLARD, C.E., BEUKERS, M.W., ROBERTS, S.M., HUNT, S.F., INGALL, A.H., MCKECHNIE, K.C., IJZERMAN, A.P. & LEFF, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475-481.
13. DRIESSEN, B., VON KUGELGEN, I. & STARKE, K. (1994). P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens. Naunyn-Schmiedebergs' Arch. Pharmacol., 350, 42-48.
14. DUNN, P.M. & BLAKELEY, A.G. (1988). Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br. J. Pharmacol., 93, 243-245.
15. 2x receptor clusters on smooth muscle cells in relation to nerve varicosities in the rat urinary bladder. J. Neurocytol., 28, 3-15.
16. 2x1 receptor clusters on smooth muscle cells in relation to nerve varicosities in the rat urinary bladder. J. Neurocytol., 27, 529-539.
17. 2x receptors and spontaneous potentials in smooth muscle cells at the intimal surface of rat tail artery. Proc. Aust. Neurosci. Soc., 10, 139.
18. HOITING, B., MOLLEMAN, A., NELEMANS, A. & DEN HERTOG, A. (1990). P2-purinoceptor-activated membrane currents and inositol tetrakisphosphate formation are blocked by suramin. Eur. J. Pharmacol., 181, 127-131.
19. HOURANI, S.M. & CHOWN, J.A. (1989). The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen. Pharmacol., 20, 413-416.
20. HOYLE, C.H., POSTORINO, A. & BURNSTOCK, G. (1995). Pre-and postjunctional effects of diadenosine polyphosphates in the guinea-pig vas deferens. J. Pharm. Pharmacol., 47, 926-931.
21. ILLES, P. & STARKE, K. (1983). An electrophysiological study of presynaptic alpha-adrenoceptors in the vas deferens of the mouse. Br. J. Pharmacol., 78, 365-373.
22. 2x purinoceptors be classified pharmacologically? Trend. Pharm. Sci., 16, 168-174.
23. KURZ, A., BULTMANN, R., DRIESSEN, B., VON KUGELGEN, I. & STARKE, K. (1994). Release of ATP in rat vas deferens: origin and role of calcium. Naunyn Schmiedebergs' Arch. Pharmacol., 350, 491-498.
24. LEONG, SK. & SINGH, G. (1990). Innervation of the monkey vas deferens. J. Anat., 171, 93-104.
25. MALLARD, N., MARSHALL, R., SITHERS, A. & SPRIGGS, B. (1992). Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens. Eur. J. Pharmacol., 220, 1-10.
26. MARJAMÄKI, A., LUOMALA, K., ALA-UOTILA, S. & SCHEININ, M. (1993). Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectivety of antagonist binding. Eur. J. Pharmacol., 246, 219-226.
27. MAYER, A., LIMBERGER, N. & STARKE, K. (1988). Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors. Naunyn-Schmiedebergs' Arch. Pharmacol., 338, 632-643.
28. MONTEITH, G.R. & ROUFOGALIS, B.D. (1995). The plasma membrane calcium pump - a physiological perspective on its regulation. Cell. Calcium, 18, 459-470.
29. REILLY, M.J. & HIRST, G.D. (1996). Differences in the responses to purinergic nerve stimulation and applied ATP in the guinea-pig vas deferens. J. Autonom. Nerv. Syst., 57, 93-100.
30. SMITH, A.B. & CUNNANE, T.C. (1996). Omega-conotoxin GVIA-resistant neurotransmitter release in postganglionic sympathetic nerve terminals. Neuroscience, 70, 817-824.
31. SMITH, A.B. & CUNNANE, T.C. (1998). Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors. Br. J. Pharmacol., 123, 167-172.
32. SNEDDON, P. (1992). Suramin inhibits excitatory junction potentials in guinea-pig isolated vas deferens. Br. J. Pharmacol., 107, 101-103.
33. SNEDDON, P., MELDRUM, L.A. & BURNSTOCK, G. (1984). Control of transmitter release in guinea-pig vas deferens by prejunctional P1-purinoceptors. Eur. J. Pharmacol., 105, 293-299.
34. STARKE, K., GOTHERT, M. & KILBINGER, H. (1989). Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev., 69, 864-989.
35. STARKE, K., VON KUGELGEN, I., DRIESSEN, B. & BULTMANN, R. (1996). ATP release and its prejunctional modulation. Ciba Found. Symp., 198, 239-249.
36. STORY, D.F., McCULLOCH, M.W., RAND, M.J. & STANDFORD-STARR, C.A. (1981). Conditions required for the inhibitory feedback loop in noradrenergie transmission. Nature, 293, 62-65.
37. STOUT, J.G. & KIRLEY, T.L. (1995). Inhibition of purified chicken gizzard smooth muscle ecto-ATPase by P2 purinoceptor antagonists. Biochem. Mol. Biol. Int., 36, 927-934.
38. TODOROV, L.D., MIHAYLOVA-TODOROVA, S., WESTFALL, T.D., SNEDDON, P., KENNEDY, C., BJUR, R.A. & WESTFALL, D.P. (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature, 387, 76-79.
39. TROUT, S.J., BRAIN, K.L, DASS, N. & CUNNANE, T.C. (1999). 'Effects of nicotine on intracellular calcium dynamics in sympathetic nerve terminal varicosities'. Br. J. Pharmacol., 127, 53P.
40. VON KUGELGEN, I., BULTMANN, R. & STARKE, K. (1989b). Effects of suramin and alpha, beta-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses. Naunyn-Schmiedebergs' Arch. Pharmacol., 340, 760-763.
41. VON KUGELGEN, I., KURZ, K. & STARKE, K. (1993). Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release. Neuroscience, 56, 263-267.
42. VON KUGELGEN, I., KURZ, K. & STARKE, K. (1994). P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmiedebergs' Arch. Pharmacol., 349, 125-132.
43. VON KUGELGEN, I., SCHOFFEL, E. & STARKE, K. (1989a). Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedebergs' Arch. Pharmacol., 340, 522-532.
44. ZIGANSHIN, A.U., ZIGANSHINA, L.E., BODIN, P., BAILEY, D. & BURNSTOCK, G. (1995). Effects of P2-purinoceptor antagonists on ecto-nucleotidase activity of guinea-pig vas deferens cultured smooth muscle cells. Biochem. Mol. Biol. Int., 36, 863-869.